{"log_id": 2462756062775398918, "direction": 0, "words_result_num": 38, "words_result": [{"probability": {"variance": 0.031677, "average": 0.779034, "min": 0.601054}, "location": {"width": 43, "top": 113, "height": 87, "left": 1115}, "words": "4二"}, {"probability": {"variance": 3.2e-05, "average": 0.993109, "min": 0.984515}, "location": {"width": 113, "top": 236, "height": 27, "left": 209}, "words": "【用法用量】"}, {"probability": {"variance": 1.3e-05, "average": 0.997191, "min": 0.986635}, "location": {"width": 243, "top": 272, "height": 30, "left": 275}, "words": "本品经由血液透析通路给药"}, {"probability": {"variance": 4.2e-05, "average": 0.993322, "min": 0.986812}, "location": {"width": 43, "top": 327, "height": 26, "left": 205}, "words": "成人"}, {"probability": {"variance": 5e-06, "average": 0.997496, "min": 0.991945}, "location": {"width": 204, "top": 359, "height": 34, "left": 249}, "words": "1)起始剂量基于体重"}, {"probability": {"variance": 0.009581, "average": 0.958184, "min": 0.607275}, "location": {"width": 759, "top": 390, "height": 42, "left": 248}, "words": "本品推荐的起始剂量为0.04-0.1μ9/kg(2.8-7μg),单次注射,给药频率不超过隔日一"}, {"probability": {"variance": 3.3e-05, "average": 0.99709, "min": 0.977978}, "location": {"width": 305, "top": 435, "height": 32, "left": 205}, "words": "次,在透析过程中的任何时间给药"}, {"probability": {"variance": 0.000454, "average": 0.990244, "min": 0.9426}, "location": {"width": 111, "top": 498, "height": 26, "left": 281}, "words": "2)剂量调整"}, {"probability": {"variance": 0.000175, "average": 0.995553, "min": 0.918947}, "location": {"width": 758, "top": 524, "height": 42, "left": 249}, "words": "目前在接受透析治疗的终末期肾功能衰竭患者中,可接受的PTH水平目标范围不超过"}, {"probability": {"variance": 0.006975, "average": 0.957201, "min": 0.583963}, "location": {"width": 792, "top": 563, "height": 39, "left": 207}, "words": "非尿毒症正常范围上限的1.5到3倍,即全段PTH(iPTH)为15.9-31.8pmol/(150-300pg/m"}, {"probability": {"variance": 0.027054, "average": 0.67194, "min": 0.582058}, "location": {"width": 93, "top": 579, "height": 31, "left": 936}, "words": " CO.LT0"}, {"probability": {"variance": 0.005844, "average": 0.984263, "min": 0.520927}, "location": {"width": 760, "top": 600, "height": 41, "left": 249}, "words": "密切监测及个体化剂量调整对于达到合适的生理终点是必要的。如果出现高钙机症或校"}, {"probability": {"variance": 0.007324, "average": 0.955249, "min": 0.683399}, "location": {"width": 799, "top": 632, "height": 45, "left": 209}, "words": "正后钙磷乘积持续高于5.2mmol2n2(65mg2d2),应减少剂量或中止用药;直到这些参数"}, {"probability": {"variance": 0.000124, "average": 0.994299, "min": 0.961903}, "location": {"width": 651, "top": 670, "height": 41, "left": 208}, "words": "恢复正常。随后,帕立骨化醇的给药量应从较低剂量重新开始。如果PTH"}, {"probability": {"variance": 0.015987, "average": 0.912468, "min": 0.660995}, "location": {"width": 134, "top": 663, "height": 35, "left": 874}, "words": "水平由于治疗而"}, {"probability": {"variance": 0, "average": 0.999629, "min": 0.997368}, "location": {"width": 302, "top": 712, "height": 32, "left": 212}, "words": "下降,药物剂量可能需要随之减少"}, {"probability": {"variance": 2e-06, "average": 0.998885, "min": 0.994208}, "location": {"width": 242, "top": 752, "height": 32, "left": 254}, "words": "下表为建议的剂量调整方法"}, {"probability": {"variance": 0.000404, "average": 0.195754, "min": 0.175649}, "location": {"width": 69, "top": 767, "height": 26, "left": 955}, "words": " ty VE"}, {"probability": {"variance": 1e-06, "average": 0.999282, "min": 0.997352}, "location": {"width": 225, "top": 808, "height": 28, "left": 513}, "words": "推荐的剂量调整指导原则"}, {"probability": {"variance": 3.9e-05, "average": 0.996076, "min": 0.976496}, "location": {"width": 275, "top": 842, "height": 31, "left": 489}, "words": "(以24周为间隔进行剂量调整"}, {"probability": {"variance": 0.018805, "average": 0.938947, "min": 0.494442}, "location": {"width": 212, "top": 882, "height": 31, "left": 311}, "words": "相对于基线的iPTH水平"}, {"probability": {"variance": 0.000171, "average": 0.987991, "min": 0.95821}, "location": {"width": 204, "top": 876, "height": 28, "left": 733}, "words": "帕立骨化醇的剂量调整"}, {"probability": {"variance": 5e-06, "average": 0.998631, "min": 0.994123}, "location": {"width": 94, "top": 921, "height": 23, "left": 368}, "words": "不变或上升"}, {"probability": {"variance": 0.028474, "average": 0.912863, "min": 0.538172}, "location": {"width": 140, "top": 928, "height": 38, "left": 788}, "words": "增加24μg"}, {"probability": {"variance": 0, "average": 0.999166, "min": 0.99825}, "location": {"width": 88, "top": 957, "height": 22, "left": 372}, "words": "下降<30%"}, {"probability": {"variance": 0.000164, "average": 0.989649, "min": 0.95764}, "location": {"width": 140, "top": 992, "height": 23, "left": 350}, "words": "30%≤下降≤60%"}, {"probability": {"variance": 5e-06, "average": 0.99779, "min": 0.993698}, "location": {"width": 100, "top": 984, "height": 24, "left": 788}, "words": "维持原剂量"}, {"probability": {"variance": 1e-05, "average": 0.996916, "min": 0.991948}, "location": {"width": 89, "top": 1028, "height": 23, "left": 376}, "words": "下降>60%"}, {"probability": {"variance": 0.002694, "average": 0.971587, "min": 0.855947}, "location": {"width": 91, "top": 1038, "height": 27, "left": 793}, "words": "减少24μg"}, {"probability": {"variance": 0.002533, "average": 0.963159, "min": 0.824571}, "location": {"width": 261, "top": 1064, "height": 28, "left": 282}, "words": " IPTH<15.9pmo/(150pg/ml"}, {"probability": {"variance": 0.003489, "average": 0.98456, "min": 0.648214}, "location": {"width": 728, "top": 1122, "height": 40, "left": 279}, "words": "旦确定了剂量,血清钙和磷应该至少每月检测一次。推荐每三个月检测一次血清iPTH"}, {"probability": {"variance": 4.9e-05, "average": 0.997347, "min": 0.963959}, "location": {"width": 585, "top": 1159, "height": 40, "left": 218}, "words": "在帕立骨化醇剂量调整期间,可能需要更加频繁地进行实验室检查"}, {"probability": {"variance": 0, "average": 0.999104, "min": 0.998129}, "location": {"width": 104, "top": 1218, "height": 26, "left": 219}, "words": "肝功能不全"}, {"probability": {"variance": 6e-06, "average": 0.998546, "min": 0.990121}, "location": {"width": 758, "top": 1248, "height": 40, "left": 262}, "words": "在轻度和中度肝功能不全患者体内,未结合的帕立骨化醇浓度与健康受试者相似,因此"}, {"probability": {"variance": 3e-06, "average": 0.998499, "min": 0.992392}, "location": {"width": 702, "top": 1283, "height": 41, "left": 221}, "words": "在这些患者人群中无需进行剂量调整。尚无在重度肝功能不全患者中的应用经验"}, {"probability": {"variance": 0.007371, "average": 0.969767, "min": 0.698816}, "location": {"width": 190, "top": 1340, "height": 34, "left": 218}, "words": "儿童患者(0-18岁)"}, {"probability": {"variance": 3e-06, "average": 0.998643, "min": 0.993692}, "location": {"width": 451, "top": 1381, "height": 36, "left": 263}, "words": "中国儿童患者使用本品的安全性和有效性尚未确立"}, {"probability": {"variance": 0.000109, "average": 0.995488, "min": 0.966058}, "location": {"width": 183, "top": 1447, "height": 31, "left": 222}, "words": "老年患者(>65岁"}], "language": 3}